---
aliases: >-
  /news/merck-glaxosmithkline-abbvie-sanofi-bristol-myers-squibb-big-pharmas-extending-digital-health-reaches
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - >-
    Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s
    Extending Digital Health Reaches
categories:
  - 'Medical Subject Headings (MeSH): Clinical Pharmacy Information Systems'
categorySlug:
  - 'medical subject headings (mesh): clinical pharmacy information systems'
categoryUrl:
  - topic/medical-subject-headings-mesh-clinical-pharmacy-information-systems
categoryLabel:
  - Clinical Pharmacy Information Systems
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2021-10-26'
description: >-
  A few weeks ago, we kickstarted a new series of articles contemplating the
  moves of pharmaceutical heavyweights in the digital health arena. The first
  batch of companies, Johnson &amp; Johnson, Pfizer
favIconImage: null
featuredImage:
  alt: >-
    Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s
    Extending Digital Health Reaches
  format: JPEG
  href: 0d8bbb93-ce90-5253-9dff-b6074d8a9432-featuredImage.jpeg
  size:
    - 1080
    - 1920
  valid: true
  workPackage: 9497
  wpAttachment:
    fileName: Curated_Featured_Image.png
    link: /api/v3/attachments/18401/content
featuredPdf: null
htmlMetaData:
  author: null
  description: >-
    Big pharma, big money, part2: what pharmaceutical giants Merck, GSK, AbbVie,
    Bristol Myers Squibb and Sanofi do in digital health.
  generator: null
  viewport: 'width=device-width,initial-scale=1'
  articlemodified_time: '2021-10-25T22:59:12'
  articlepublished_time: '2021-10-26T08:00:00'
  msvalidate.01: null
  ogdescription: >-
    Big pharma, big money, part2: what pharmaceutical giants Merck, GSK, AbbVie,
    Bristol Myers Squibb and Sanofi do in digital health.
  ogimage: >-
    https://cdn.medicalfuturist.com/wp-content/uploads/2021/10/tmf_article_298-01.png
  ogsite_name: The Medical Futurist
  ogtitle: >-
    Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s
    Extending Digital Health Reaches - The Medical Futurist
  ogtype: article
  ogupdated_time: '2021-10-25T22:59:12'
  ogurl: 'https://medicalfuturist.com/big-pharma-part-2/'
  yandex-verification: null
  robots: noodp
  fbapp_id: '1796753533873796'
  oglocale: en_US
  fbadmins: '100000702732950'
  articlepublisher: 'https://www.facebook.com/medicalfuturist'
  google-site-verification: zbobS_w-zKE2TUJArPSIkWdHdx77XjEfnBwC_EZhELY
  keywords: null
id: 9497
identifier: News
lastMod: '2021-10-26T15:03:12.454280Z'
link:
  brand: medicalfuturist.com
  href: 'https://medicalfuturist.com/big-pharma-part-2/'
  original: 'https://medicalfuturist.com/big-pharma-part-2/'
href: 'https://medicalfuturist.com/big-pharma-part-2/'
original: 'https://medicalfuturist.com/big-pharma-part-2/'
mastHead: NEWS
mdName: 0d8bbb93-ce90-5253-9dff-b6074d8a9432.md
openGraphMetaData:
  ogdescription: >-
    Big pharma, big money, part2: what pharmaceutical giants Merck, GSK, AbbVie,
    Bristol Myers Squibb and Sanofi do in digital health.
  ogtitle: >-
    Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s
    Extending Digital Health Reaches - The Medical Futurist
  ogurl: 'https://medicalfuturist.com/big-pharma-part-2/'
  ogimage: >-
    https://cdn.medicalfuturist.com/wp-content/uploads/2021/10/tmf_article_298-01.png
  ogsite_name: The Medical Futurist
  ogtype: article
  ogupdated_time: '2021-10-25T22:59:12'
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: 'https://medicalfuturist.com/big-pharma-part-2/'
  medigyTopics:
    - 'Medical Subject Headings (MeSH): Clinical Pharmacy Information Systems'
  sourceUrl: 'https://medicalfuturist.com/big-pharma-part-2/'
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  medicalfuturist-merck-glaxosmithkline-abbvie-sanofi-bristol-myers-squibb-big-pharmas-extending-digital-health-reaches
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: >-
  Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s
  Extending Digital Health Reaches
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: Prescription Drug Monitoring Program (PDMP)
    permalink: /offering/prescription-drug-monitoring-program-pdmp
    categories:
      - 'Medical Subject Headings (MeSH): Clinical Pharmacy Information Systems'
    offeringId: 6562
  - label: DoseMe
    permalink: /offering/doseme
    categories:
      - 'Healthcare IT News: Precision Health'
      - 'Medical Subject Headings (MeSH): Clinical Pharmacy Information Systems'
    offeringId: 5786
twitterMetaData:
  twittercard: null
  twitterdescription: >-
    Big pharma, big money, part2: what pharmaceutical giants Merck, GSK, AbbVie,
    Bristol Myers Squibb and Sanofi do in digital health.
  twittertitle: >-
    Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s
    Extending Digital Health Reaches - The Medical Futurist
  twitterimage: >-
    https://cdn.medicalfuturist.com/wp-content/uploads/2021/10/tmf_article_298-01.png
  twitterurl: null
---
<p>A few weeks ago, we kickstarted <a href="https://medicalfuturist.com/big-pharma-part-one">a new series of articles</a> contemplating the moves of pharmaceutical heavyweights in the digital health arena. The first batch of companies, Johnson &amp; Johnson, Pfizer, Bayer and Novartis, seem to have some interest in remote healthcare solutions and DTx.&nbsp;</p><p>In this second article, we will explore which trends pharma giants Merck, GlaxoSmithKline, AbbVie, Sanofi and Bristol Myers Squibb are eyeing.</p>